Pituitary and Parathyroid Disorders

  • Anoop James George
  • Suresh S. David


Pituitary failure occurs due to multiple reasons including genetic abnormalities, trauma, infections, empty sella syndrome, Sheehan’s syndrome, etc.


Pituitary Adenoma Parathyroid Gland Pituitary Tumour Primary Hyperparathyroidism Parathyroid Adenoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mancall, EL, Brock, DG, editors. “Cranial Fossae”. Gray’s clinical anatomy. Philadelphia, PA: Elsevier Health Sciences; 2011. p. 154. ISBN 9781437735802
  2. 2.
    Boron WF, Boulpaep EL. Medical physiology. 2nd ed. Philadelphia: Saunders Elsevier; 2009. p. 1016–7.Google Scholar
  3. 3.
    Musolino NR, Marino Junior R, Bronstein MD. Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201–995. Clin J Pain. 1990;6:243–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995;80:2190–7.PubMedGoogle Scholar
  5. 5.
    Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 1997;11:433–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Brain Tumor Registry of Japan. Neurol Med Chir (Tokyo). 1992;32(7 spec no):381–547. Google Scholar
  7. 7.
    Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am. 1999;28:81–117, vi.CrossRefGoogle Scholar
  8. 8.
    Melmed S. Acromegaly. In: DeGroot LJ, Jameson JL, Burger H, et al., editors. Endocrinology. 4th ed. Philadelphia: WB Saunders; 2001. p. 300–12.Google Scholar
  9. 9.
    Arnold AC. Neuro-ophthalmologic evaluation of pituitary disorders. In: Melmed S, editor. The pituitary. Malden: Blackwell; 2002. p. 687–708.Google Scholar
  10. 10.
    Turner HE, Nagy Z, Gatter KC, et al. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab. 2000;85:1159–62.CrossRefPubMedGoogle Scholar
  11. 11.
    Kucharczyk W, Lenkinski RE, Kucharczyk J, Henkelman RM. The effect of phospholipid vesicles on the NMR relaxation of water: an explanation for the MR appearance of the neurohypophysis? AJNR Am J Neuroradiol. 1990;11:693–700.PubMedGoogle Scholar
  12. 12.
    Vidal S, Rotondo F, Horvath E, Kovacs K, Scheithauer BW. Immunocytochemical localization of mast cells in lymphocytic hypophysitis. Am J Clin Pathol. 2002;117:478–83.CrossRefPubMedGoogle Scholar
  13. 13.
    Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391–403.CrossRefPubMedGoogle Scholar
  14. 14.
    Pallan S, Khan A. Primary hyperparathyroidism: update on presentation, diagnosis, and management in primary care. Can Fam Physician. 2011;57(2):184–9.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Malone JP, Srivastava A, Khardori R. Hyperparathyroidism and multiple endocrine neoplasia. Otolaryngol Clin N Am. 2004;37(4):715–36, viii.CrossRefGoogle Scholar
  16. 16.
    Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin N Am. 2004;37(4):701–13, vii–viii.CrossRefGoogle Scholar
  17. 17.
    Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004;69(2):333–9.PubMedGoogle Scholar
  18. 18.
    Stearns M, Cox J. Parathyroid disease: symptoms, differential diagnosis, and management. In: Arora A, Tolley NS, Tuttle RM, editors. A practical manual of thyroid and parathyroid disease. Chichester: Wiley- Blackwell; 2010. p. 145–63.Google Scholar
  19. 19.
    Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2(9):494–503.CrossRefPubMedGoogle Scholar
  20. 20.
    Michels TC, Kelly KM. Parathyroid disorders. Am Fam Physician. 2013;88(4):249–57.PubMedGoogle Scholar
  21. 21.
    Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist. 2007;12(6):644–53.CrossRefPubMedGoogle Scholar
  22. 22.
    Stack BC, Randolph G. Parathyroid disease: investigations. In: Arora A, Tolley NS, Tuttle RM, editors. A practical manual of thyroid and parathyroid disease. Chichester: Wiley-Blackwell; 2010. p. 164–73.CrossRefGoogle Scholar
  23. 23.
    Marsh DJ, Gimm O. Multiple endocrine neoplasia: types 1 and 2. Adv Otorhinolaryngol. 2011;70:84–90.PubMedGoogle Scholar
  24. 24.
    Khan AA, Bilezikian JP, Potts Jr JT. Guest Editors for the Third International Workshop on Asymptomatic Primary Hyperparathyroidism. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab. 2009;94(2):333–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Bilezikian JP, Khan AA, Potts Jr JT. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–9.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Dillon ML, Frazee LA. Cinacalcet for the treatment of primary hyperparathyroidism. Am J Ther. 2011;18(4):313–22.CrossRefPubMedGoogle Scholar
  27. 27.
    Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab. 2009;94(2):373–81.CrossRefPubMedGoogle Scholar
  28. 28.
    Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemic [published correction appears in BMJ. 2008;336(7659). Accessed Jun 30, 2015]. BMJ. 2008;336(7656):1298–302.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Fuleihan GE, Silverberg SJ. Diagnosis and differential diagnosis of primary hyperparathyroidism. UpToDate. 11 Feb 2011. primaryhyperparathyroidism[subscription required]. Accessed 30 Jun 2015.

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Emergency MedicinePushpagiri Medical College HospitalThiruvallaIndia

Personalised recommendations